BDBM492290 5-[6-(tert-Butylamino)-4-(difluoromethyl)-3-pyridyl]-4-[(2S)-4,4-difluoro-2-methyl-pyrrolidine-1-carbonyl]-N-(1,1-dioxothian-4-yl)thiazole-2-carboxamide::US10975068, Example 431

SMILES C[C@H]1CC(F)(F)CN1C(=O)c1nc(sc1-c1cnc(NC(C)(C)C)cc1C(F)F)C(=O)NC1CCS(=O)(=O)CC1

InChI Key InChIKey=AOVVNOLHFNHGPF-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 492290   

TargetNuclear receptor ROR-gamma(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM492290(5-[6-(tert-Butylamino)-4-(difluoromethyl)-3-pyridy...)
Affinity DataKd:  0.360nMAssay Description:1,8-ANS (Invitrogen) was used as a fluorescent dye. Protein and compound solutions are dispensed into black 384-well polypropylene PCR microplates (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2021
Entry Details
US Patent